Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 55111-453

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 55111-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton150mg (Carton150mg)

Packaging label for venlafaxine hydrochloride extended-release capsules, USP 150 mg by Dr. Reddy's Laboratories Ltd. The label indicates capsules are unit-dose with 100 capsules per carton (10 blister packs of 10 capsules each). It includes storage instructions and directs pharmacists to dispense with the accompanying medication guide.*

FDA Label Image

Carton37.5mg (Carton37.5mg)

The packaging label for venlafaxine hydrochloride extended-release capsules, USP 37.5 mg by Dr. Reddy's Laboratories Ltd. The label indicates a count of 100 capsules in unit-dose blister packs. It includes storage instructions and a pharmacist notice to dispense with the accompanying medication guide. The design features the Dr. Reddy's Laboratories logo and emphasizes the dosage strength prominently.*

FDA Label Image

Carton75mg (Carton75mg)

Venlafaxine hydrochloride 75 mg extended-release capsules, USP packaging label by Dr. Reddy's Laboratories Ltd. The label indicates a unit-dose package with 100 capsules (10 blister cards of 10 capsules each). The label features the product name, strength, dosage form, NDC number, storage instructions, and a pharmacist dispensing note with medication guide reminder.*

FDA Label Image

Container150mg (Container150mg)

Label for venlafaxine hydrochloride extended-release capsules, USP, 150 mg strength, in a 100-capsule package. The label includes NDC 55111-455-01 and is from Dr. Reddy's Laboratories Ltd. It instructs pharmacists to dispense with an accompanying medication guide, lists venlafaxine hydrochloride as the active ingredient, and provides storage instructions and contact information.*

FDA Label Image

Container37.5mg (Container37.5mg)

Label for venlafaxine hydrochloride extended-release capsules, USP 37.5 mg by Dr. Reddy's Laboratories Ltd. The label indicates a package containing 100 capsules. It includes a caution to dispense with the accompanying medication guide and standard storage instructions to store at controlled room temperature. The label is marked for prescription use only.*

FDA Label Image

Container75mg (Container75mg)

Label for venlafaxine hydrochloride extended-release capsules, USP, 75 mg, from Dr. Reddy's Laboratories Ltd. The label indicates a package of 100 capsules with a note for pharmacists to dispense with the medication guide. Storage instructions recommend 20-25°C in a controlled room temperature environment.*

FDA Label Image

Figure1

A pharmacokinetic interaction plot illustrating fold changes in Cmax, AUC, and ODV values of venlafaxine when co-administered with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 extensive and poor metabolizers), indinavir, metoprolol, imipramine, and lithium. Each drug's impact on venlafaxine pharmacokinetics is shown relative to a reference value, accompanied by clinical use recommendations.*

FDA Label Image

Figure2

A pharmacokinetic interaction chart showing PK fold changes and 90% confidence intervals for venlafaxine hydrochloride with various interacting drugs. It lists interacting drugs and analytes, plotting changes in Cmax and AUC relative to reference values, alongside clinical recommendations for dose adjustments or monitoring.*

FDA Label Image

Figure3

A chart depicting pharmacokinetic changes of venlafaxine in special populations. It shows fold changes and 90% confidence intervals for Cmax, AUC, and other parameters across conditions like hepatic impairment, renal impairment, CYP2D6 metabolizer status, age over 60, and gender. Recommendations for dose adjustments accompany the data.*

FDA Label Image

Structure (Structure)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including a cyclohexane ring, a phenyl ring with a methoxy group, and a dimethylamino ethanol side chain, labeled with the hydrochloride (HCl) salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.